Prognostic impact of the MDM2SNP309 allele in leukemia and lymphoma.

Oncotarget

Volumn 1, Issue 3, 2010, Pages 168-174

  Post, Sean M ^a   Pant, Vinod ^b   Abbas, Hussein ^b   Quintás Cardama, Alfonso ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MDM2 PROTEIN, HUMAN; PROTEIN MDM2;

ANIMAL; DISEASE MODEL; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; HUMAN; LEUKEMIA; LYMPHOMA; METABOLISM; MOUSE; PATHOLOGY; PROGNOSIS; PROMOTER REGION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; DISEASE MODELS, ANIMAL; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKEMIA; LYMPHOMA; MICE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-MDM2;

EID: 80054682401     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.123     Document Type: Review

References (0)